{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:36:14Z","timestamp":1791311774996,"version":"4.3.1"},"update-to":[{"DOI":"10.1002\/14651858.cd008782.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T00:00:00Z","timestamp":1402358400000}}],"reference-count":127,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008782.pub4","type":"journal-article","created":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T10:46:06Z","timestamp":1402397166000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)"],"prefix":"10.1002","volume":"2014","author":[{"given":"Craig","family":"Ritchie","sequence":"first","affiliation":[{"name":"Imperial College London; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadja","family":"Smailagic","sequence":"additional","affiliation":[{"name":"University of Cambridge; Institute of Public Health; Forvie Site Robinson Way Cambridge UK CB2 0SR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna H","family":"Noel-Storr","sequence":"additional","affiliation":[{"name":"University of Oxford; Radcliffe Department of Medicine; Room 4401c (4th Floor) John Radcliffe Hospital, Headington Oxford UK OX3 9DU"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yemisi","family":"Takwoingi","sequence":"additional","affiliation":[{"name":"University of Birmingham; Public Health, Epidemiology and Biostatistics; Edgbaston Birmingham UK B15 2TT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Flicker","sequence":"additional","affiliation":[{"name":"University of Western Australia; Western Australian Centre for Health & Ageing - WACHA; Crawley Perth Western Australia Australia 6014"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam E","family":"Mason","sequence":"additional","affiliation":[{"name":"Imperial College Medical School; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert","family":"McShane","sequence":"additional","affiliation":[{"name":"University of Oxford; Radcliffe Department of Medicine; Room 4401c (4th Floor) John Radcliffe Hospital, Headington Oxford UK OX3 9DU"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,6,10]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD008782.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000252773","article-title":"Subcortical vascular dementia biomarker pattern in mild cognitive impairment","volume":"28","author":"Bjerke","year":"2009","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.neurobiolaging.2008.03.027","article-title":"Evaluation of plasma A\u00df40 and A\u00df42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment","volume":"31","author":"Hanson","year":"2010","journal-title":"Neurobiology of Aging"},{"issue":"4","key":"10.1002\/14651858.CD008782.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3233\/JAD-2012-120019","article-title":"Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment","volume":"30","author":"Mattsson","year":"2012","journal-title":"Journal of Alzheimer's Disease"},{"issue":"4","key":"10.1002\/14651858.CD008782.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2009.1064","article-title":"CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment","volume":"302","author":"Mattsson","year":"2009","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1136\/jnnp.2004.050385","article-title":"The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition","volume":"76","author":"Nordlund","year":"2005","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/jnnp.2008.171066","article-title":"Two-year outcome of MCI subtypes and aetiologies in the Goteborg MCI study","volume":"81","author":"Nordlund","year":"2010","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD008782.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000234912","article-title":"Cognitive reserve in relation to abeta42 in patients converting from MCI to dementia - a follow-up report","volume":"28","author":"Rolstad","year":"2009","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000203130","article-title":"Biomarkers in relation to cognitive reserve in patients with mild cognitive impairment - proof of concept","volume":"27","author":"Rolstad","year":"2009","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"3","key":"10.1002\/14651858.CD008782.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000333034","article-title":"Progression from mild to pronounced MCI is not associated with cerebrospinal fluid biomarker deviations","volume":"32","author":"Wallin","year":"2011","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"5","key":"10.1002\/14651858.CD008782.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1159\/000216841","article-title":"Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE \u03f54\/\u03f54 genotype","volume":"27","author":"Blom","year":"2009","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0011|cit11","doi-asserted-by":"crossref","unstructured":"Brys M Pirraglia E Rich K Rolstad S Mosconi L Switalski R Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment Neurobiology of Aging 2009 682 90","DOI":"10.1016\/j.neurobiolaging.2007.08.010"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3233\/JAD-2010-101293","article-title":"CSF levels of heart fatty acid binding protein are altered during early phases of Alzheimer's disease","volume":"22","author":"Chiasserini","year":"2010","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jns.2011.03.005","article-title":"The relationship of plasma A\u00df levels to dementia in aging individuals with mild cognitive impairment","volume":"305","author":"Fei","year":"2011","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0014|cit14","article-title":"Supporting evidence of the Alzheimer's disease biomarker dynamic model in patients with mild cognitive impairment","author":"Galluzzi","year":"2012","journal-title":"Conference Publication: Alzheimer's Association International Conference 2012 Vancouver, BC Canada. Conference Start: 20120714 Conference End: 20120719. Conference Publication:(var.pagings)."},{"key":"10.1002\/14651858.CD008782.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1007\/s00415-010-5650-0","article-title":"The new Alzheimer's criteria in a naturalistic series of patients with mild cognitive impairment","volume":"257","author":"Galluzzi","year":"2010","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0016|cit16","article-title":"Accuracy of different biomarkers to predict progression from mild cognitive impairment to probable Alzheimer's dementia in two independent clinical series","author":"Prestia","year":"2012","journal-title":"Conference Publication: Alzheimer's Association International Conference 2012 Vancouver, BC Canada. Conference Start: 20120714 Conference End: 20120719. Conference Publication:(var.pagings)"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.mp.4001473","article-title":"Value of CSF \u00df-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment","volume":"9","author":"Hampel","year":"2004","journal-title":"Molecular Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD008782.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archgenpsychiatry.2011.155","article-title":"Cerebrospinal fluid levels of beta-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia","volume":"69","author":"Buchhave","year":"2012","journal-title":"Archives of General Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD008782.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1159\/000137379","article-title":"Cube copying test in combination with rCBF or CSF A beta 42 predicts development of Alzheimer's disease","volume":"25","author":"Buchhave","year":"2008","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipientt Alzheimer's disease in patients with mild cognitive impairment: a follow-up","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.neurobiolaging.2008.03.027","article-title":"Evaluation of plasma A\u00df40 and A\u00df42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment","volume":"31","author":"Hansson","year":"2010","journal-title":"Neurobiology of Aging"},{"issue":"5","key":"10.1002\/14651858.CD008782.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000100926","article-title":"Prediction of Alzheimer's disease using the CSF A\u00df42\/A\u00df40 ratio in patients with mild cognitive impairment","volume":"23","author":"Hansson","year":"2007","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"7","key":"10.1002\/14651858.CD008782.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1212\/WNL.0b013e3182477eed","article-title":"Age and diagnostic performance of Alzheimer disease CSF biomarkers","volume":"78","author":"Mattsson","year":"2012","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD008782.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2009.1064","article-title":"CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment","volume":"302","author":"Mattsson","year":"2009","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0025|cit25","doi-asserted-by":"crossref","unstructured":"Hertze J Minthon L Zetterberg H Vanmechelen E Blennow K Hansson O Evaluation of CSF biomarkers as predictors of Alzheimer's disease: a clinical follow-up study of 4.7 years Journal of Alzheimer's Disease 2010 1119 28","DOI":"10.3233\/JAD-2010-100207"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0026|cit26","article-title":"Comparison of brief cognitive tests and csf analysis in predicting Alzheimer's disease in mild cognitive impairment: Six-year follow-up study. Alzheimer's and Dementia 2012","author":"Palmqvist","year":"2012","journal-title":"Conference Publication: Alzheimer's Association International Conference 2012 Vancouver, BC Canada. Conference Start: 20120714 Conference End: 20120719. Conference Publication:(var.pagings)."},{"key":"10.1002\/14651858.CD008782.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1212\/01.WNL.0000156914.16988.56","article-title":"CSF Abeta42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment","volume":"64","author":"Herukka","year":"2005","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.neurobiolaging.2006.02.001","article-title":"CSF A\u00df42, tau and phosphorylated tau, APOE \u03f54 allele and MCI type in progressive MCI","volume":"28","author":"Herukka","year":"2007","journal-title":"Neurobiology of Aging"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3233\/JAD-2008-14105","article-title":"CSF A\u00df42, tau and phosphorylated tau correlate with medial temporal lobe","volume":"14","author":"Herukka","year":"2008","journal-title":"Journal of Alzheimer's Disease"},{"issue":"4","key":"10.1002\/14651858.CD008782.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3233\/JAD-2011-101911","article-title":"Longitudinal changes of CSF biomarkers in Alzheimer's disease","volume":"25","author":"Seppala","year":"2011","journal-title":"Journal of Alzheimer's Disease"},{"issue":"8","key":"10.1002\/14651858.CD008782.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.neurobiolaging.2009.08.006","article-title":"Progression from MCI to AD: Predictive value of CSF A\u00df42 is modified by APOE genotype","volume":"32","author":"Kester","year":"2011","journal-title":"Neurobiology of Aging"},{"issue":"2","key":"10.1002\/14651858.CD008782.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3233\/JAD-2011-111694","article-title":"Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease","volume":"29","author":"Rossum","year":"2012","journal-title":"Journal of Alzhemer's Disease"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s11064-011-0438-x","article-title":"Biomarkers of Alzheimer's disease in the cerebrospinal fluid of Spanish patients with mild cognitive impairment","volume":"36","author":"Monge-Argiles","year":"2011","journal-title":"Neurochemical Research"},{"issue":"Special Issue S","key":"10.1002\/14651858.CD008782.pub4-BIB0034|cit34","first-page":"463","article-title":"Rapid progression from mild cognitive impairment to Alzheimer's disease related with CSF biomarker abnormalities","volume":"19 Suppl 1","author":"Monge-Argiles","year":"2012","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000229023","article-title":"Progression of mild cognitive impairment to Alzheimer's disease: improved diagnostic value of the combined use of N200 latency and \u00df-amyloid(1-42) levels","volume":"28","author":"Papaliagkas","year":"2009","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2174\/156720510791162421","article-title":"Combination of P300 and CSF A\u00dfamyloid1-42 assays may provide a potential tool in the early diagnosis of Alzheimer's disease","volume":"7","author":"Papalliagkas","year":"2010","journal-title":"Current Alzheimer Research"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.mad.2005.09.022","article-title":"Diagnosing prodromal Alzheimer's disease: Role of CSF biochemical markers","volume":"127","author":"Parnetti","year":"2006","journal-title":"Mechanisms of Ageing and Development"},{"issue":"2","key":"10.1002\/14651858.CD008782.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neuroimage.2009.02.015","article-title":"Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls","volume":"46","author":"Chou","year":"2009","journal-title":"Neuroimage"},{"issue":"12","key":"10.1002\/14651858.CD008782.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"2322.e19","DOI":"10.1016\/j.neurobiolaging.2010.05.023","article-title":"Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification","volume":"32","author":"Davatzikos","year":"2011","journal-title":"Neurobiology of Aging"},{"issue":"8","key":"10.1002\/14651858.CD008782.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/archneurol.2010.179","article-title":"Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people","volume":"67","author":"Meyer","year":"2010","journal-title":"Archives of Neurology"},{"issue":"7","key":"10.1002\/14651858.CD008782.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.neurobiolaging.2010.10.019","article-title":"Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance","volume":"33","author":"Ewers","year":"2012","journal-title":"Neurobiology of Aging"},{"issue":"17","key":"10.1002\/14651858.CD008782.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1212\/WNL.0b013e3182343314","article-title":"Predicting MCI outcome with clinically available MRI and CSF biomarkers","volume":"77","author":"Heister","year":"2011","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/brain\/awq277","article-title":"Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease","volume":"133","author":"Jack","year":"2010","journal-title":"Brain"},{"issue":"10","key":"10.1002\/14651858.CD008782.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/archneurol.2011.123","article-title":"Longitudinal change of biomarkers in cognitive decline","volume":"68","author":"Lo","year":"2011","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0045|cit45","article-title":"Discordance for hippocampal atrophy and amyloid burden in amnestic mild cognitive impairment may identify distinct subgroups of patients","author":"Novak","year":"2012","journal-title":"Alzheimer's Association International Conference 2012 Vancouver, BC Canada. Conference Start: 20120714 Conference End: 20120719. Conference Publication:(var.pagings)"},{"issue":"1","key":"10.1002\/14651858.CD008782.pub4-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archneurol.2010.334","article-title":"Cerebrospinal fluid profiles and prospective course and outcome in patients with amnestic mild cognitive impairment","volume":"68","author":"Okonkwo","year":"2011","journal-title":"Archives of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD008782.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3233\/JAD-2012-111703","article-title":"Value of diagnostic tests to predict conversion to Alzheimer's disease in young and old patients with amnestic mild cognitive impairment","volume":"29","author":"Schmand","year":"2012","journal-title":"Journal of Alzheimer's Disease 2012"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1212\/WNL.0b013e3181e7ca82","article-title":"Serial MRI and CSF biomarkers in normal aging, MCI and AD","volume":"75","author":"Vemuri","year":"2010","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0050|cit50","first-page":"1","article-title":"Prediction of Alzheimer's disease in subjects with amnestic and non-amnestic MCI","volume":"In press","author":"Vos","year":"2013","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2003.08.011","article-title":"Cerebrospinal fluid markers for prediction of Alzheimer's disease","volume":"352","author":"Zetterberg","year":"2003","journal-title":"Neuroscience Letters"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000097354","article-title":"Differential CSF biomarker levels in APOE-4-positive and-negative patients memory impairment","volume":"23","author":"Andersson","year":"2007","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0053|cit53","doi-asserted-by":"crossref","unstructured":"Andersson C Blennow K Almkvist O Andreasen N Engfeldt P Johansson SE Increasing CSF phospho-tau levels during cognitive decline and progression to dementia Neurobiology of Aging 2008 1466 73","DOI":"10.1016\/j.neurobiolaging.2007.03.027"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0054|cit54","doi-asserted-by":"crossref","unstructured":"Andreasen N Gottfries J Vanmechelen E Vanderstichele H Davidson P Blennow K Evaluation of CSF biomarkers for axonal and neuronal degeneration, gliosis, and beta-amyloid metabolism in Alzheimer's disease Journal of Neurology, Neurosurgery, and Psychiatry 2001 557 8","DOI":"10.1136\/jnnp.71.4.557"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0055|cit55","doi-asserted-by":"crossref","unstructured":"Andreasen N Vanmechelen E Vanderstichele H Davidsson P Blennow K Cerebrospinal fluid levels of total-tau, phospho-tau and A beta 42 predicts development of Alzheimer's disease in patients with mild cognitive impairment Acta Neurologica Scandinavica. Supplementum 2003 47 51","DOI":"10.1034\/j.1600-0404.107.s179.9.x"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0056|cit56","doi-asserted-by":"crossref","unstructured":"Bertens D Scheltens P Visser PJ Use of biomarkers as endpoint in trials with subjects with preclinical and prodromal Alzheimer's disease: an ADNI study Alzheimer's and Dementia 2012","DOI":"10.1016\/j.jalz.2012.05.1638"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0057|cit57","doi-asserted-by":"crossref","unstructured":"Blasko I Jellinger K Kemmler G Krampla W Jungwirth S Wichart I Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine Neurobiology of Aging 2008 1 11","DOI":"10.1016\/j.neurobiolaging.2006.09.002"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0058|cit58","doi-asserted-by":"crossref","unstructured":"Bouwman FH van der Flier WM Schoonenboom NS van Elk EJ Kok A Rijmen F Longitudinal changes of CSF biomarkers in memory clinic patients Neurology 2007 1006 11","DOI":"10.1212\/01.wnl.0000271375.37131.04"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0059|cit59","doi-asserted-by":"crossref","unstructured":"de Leon MJ Segal S Tarshish CY DeSanti S Zinkowski R Mehta PD Longitudinal cerebrospinal fluid tau load increases in mild cognitive impairment Neuroscience Letters 2002 183 6","DOI":"10.1016\/S0304-3940(02)01038-8"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0060|cit60","doi-asserted-by":"crossref","unstructured":"de Leon MJ DeSanti S Zinkowski R Mehta PD Pratico D Segal S Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment Neurobiology of Aging 2006 394 401","DOI":"10.1016\/j.neurobiolaging.2005.07.003"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0061|cit61","doi-asserted-by":"crossref","unstructured":"Ellis K Maruff P Martins R Masters C McBride S Macaulay L Rates of conversion to MCI and Alzheimer's in the australian imaging biomarkers and lifestyle (AIBL) cohort over 36 months Alzheimer's and Dementia 2012","DOI":"10.1016\/j.jalz.2012.05.1312"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0062|cit62","doi-asserted-by":"crossref","unstructured":"Fagan AM Roe CM Xiong C Mintun MA Morris JC Holtzman DM Cerebrospinal fluid tau\/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults Archives of Neurology 2007 343 9","DOI":"10.1001\/archneur.64.3.noc60123"},{"issue":"4","key":"10.1002\/14651858.CD008782.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1590\/S1516-44462008000400003","article-title":"Mild cognitive impairment: cognitive screening or neuropsychological assessment?","volume":"30","author":"Diniz","year":"2008","journal-title":"Revista Brasileira de Psiquiatria"},{"issue":"3","key":"10.1002\/14651858.CD008782.pub4-BIB0064|cit64","first-page":"216","article-title":"Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment","volume":"32","author":"Forlenza","year":"2010","journal-title":"Revista Brasileira de Pisquiatria"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0065|cit65","doi-asserted-by":"crossref","unstructured":"Gustafson DR Skoog I Rosengren L Zetterberg H Blennow K Cerebrospinal fluid beta-amyloid 1-42 concentration may predict cognitive decline in older women Journal of Neurology, Neurosurgery, and Psychiatry 2007 461 4","DOI":"10.1136\/jnnp.2006.100529"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.neurobiolaging.2008.03.027","article-title":"Evaluation of plasma A\u00df40 and A\u00df42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment","volume":"31","author":"Hansson","year":"2010","journal-title":"Neurobiology of Aging"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/jnnp.2008.171066","article-title":"Two-year outcome of MCI subtypes and aetiologies in the Goteborg MCI study","volume":"81","author":"Nordlund","year":"2010","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0068|cit68","doi-asserted-by":"crossref","unstructured":"Ivanoiu A Sindic CJ Cerebrospinal fluid TAU protein and amyloid beta42 in mild cognitive impairment: prediction of progression to Alzheimer's disease and correlation with the neuropsychological examination Neurocase 2005 32 9","DOI":"10.1080\/13554790490896901"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3233\/JAD-2011-101878","article-title":"Cerebrospinal fluid biomarkers for alzheimer's disease: diagnostic performance in a homogenous mono-center population","volume":"24","author":"Johansson","year":"2011","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0070|cit70","doi-asserted-by":"crossref","unstructured":"Li G Sokal I Quinn JF Leverenz JB Brodey M Schellenberg GD CSF tau\/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study Neurology 2007 631 9","DOI":"10.1212\/01.wnl.0000267428.62582.aa"},{"issue":"19","key":"10.1002\/14651858.CD008782.pub4-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1664\u201371","DOI":"10.1212\/01.wnl.0000306696.82017.66","article-title":"Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study","volume":"70","author":"Lopez","year":"2008","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0072|cit72","doi-asserted-by":"crossref","unstructured":"Maruyama M Arai H Sugita M Tanji H Higuchi M Okamura N Cerebrospinal fluid amyloid beta(1-42) levels in the mild cognitive impairment stage of Alzheimer's disease Experimental Neurology 2001 433 6","DOI":"10.1006\/exnr.2001.7814"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0073|cit73","doi-asserted-by":"crossref","unstructured":"Mayeux R Honig LS Tang MX Manly J Stern Y Schupf N Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk Neurology 2003 1185 90","DOI":"10.1212\/01.WNL.0000091890.32140.8F"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0074|cit74","doi-asserted-by":"crossref","unstructured":"Parnetti L Chiasserini D Eusebi P Giannandrea D Bellomo G De Carlo C Performance of Abeta1-40, Abeta1-42, total tau, and phosphorylated tau as predictors of dementia in a cohort of patients with mild cognitive impairment Journal of Alzheimer's Disease 2012 229 38","DOI":"10.3233\/JAD-2011-111349"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1212\/WNL.0b013e318221ad47","article-title":"CSF soluble amyloid precursor proteins in the diagnosis of incipient Alzheimer disease","volume":"77","author":"Perneczky","year":"2011","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0076|cit76","doi-asserted-by":"crossref","unstructured":"Pesaresi M Lovati C Bertora P Mailland E Galimberti D Scarpini E Plasma levels of beta-amyloid (1-42) in Alzheimer's disease and mild cognitive impairment Neurobiology of Aging 2006 904 5","DOI":"10.1016\/j.neurobiolaging.2006.03.004"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0077|cit77","doi-asserted-by":"crossref","unstructured":"Ramakers I Verhey FRJ Vos S Koehler S Van Praag L Scheltens P Cerebrospinal fluid biomarkers for Alzheimer's disease and specific cognitive decline in subjects with mild cognitive impairment Alzheimer's and Dementia 2012","DOI":"10.1016\/j.jalz.2012.05.1690"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/archneur.59.11.1729","article-title":"Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer's disease in subjects with mild cognitive impairment","volume":"59","author":"Riemenschneider","year":"2002","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1136\/jnnp.2010.205757","article-title":"Plasma A\u00df42 and A\u00df40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study","volume":"81","author":"Seppala","year":"2010","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0080|cit80","doi-asserted-by":"crossref","unstructured":"Skoog I Davidsson P Aevarsson O Vanderstichele H Vanmechelen E Blennow K Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: a population-based study in 85-year-olds Dementia and Geriatric Cognitive Disorders 2003 169 76","DOI":"10.1159\/000068478"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0081|cit81","doi-asserted-by":"crossref","unstructured":"Snider BJ Fagan AM Roe C Shah AR Grant EA Xiong C Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type Archives of Neurology 2009 638 45","DOI":"10.1001\/archneurol.2009.55"},{"issue":"2","key":"10.1002\/14651858.CD008782.pub4-BIB0082|cit82","first-page":"133","article-title":"Predictors of amnesic mild cognitive impairment to dementia progression: a two-year prospective study","volume":"16","author":"Sobow","year":"2007","journal-title":"Postepy Psychiatrii i Neurologii"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3233\/JAD-2009-1144","article-title":"Amyloid-\u00df42 plasma levels are elevated in amnestic mild cognitive impairment","volume":"18","author":"Cammarata","year":"2009","journal-title":"Journal of Alzheimer's Disease"},{"issue":"7","key":"10.1002\/14651858.CD008782.pub4-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/archneurol.2010.137","article-title":"Elevation of \u00df-amyloid1-42 autoantibodies in the blood of amnestic patients with mild cognitive impairments","volume":"67","author":"Storace","year":"2010","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0085|cit85","unstructured":"Uspenskaya Neurochemical markers of neurodegeneration in the early diagnosis of Alzheimer\u2019s disease, vascular and mixed dementia 2010"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0086|cit86","doi-asserted-by":"crossref","unstructured":"Vanderstichele H De Meyer G Andreasen N Kostanjevecki V Wallin A Olsson A Amino-truncated beta-amyloid42 peptides in cerebrospinal fluid and prediction of progression of mild cognitive impairment Clinical Chemistry 2005 1650 60","DOI":"10.1373\/clinchem.2005.051201"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0087|cit87","doi-asserted-by":"crossref","unstructured":"Visser PJ Verhey F Knol DL Scheltens P Wahlund LO Freund-Levi Y Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study Lancet Neurology 2009 619 27","DOI":"10.1016\/S1474-4422(09)70139-5"},{"issue":"9","key":"10.1002\/14651858.CD008782.pub4-BIB0088|cit88","first-page":"647","article-title":"The role of CSF markers in the early diagnosis of Alzheimer's disease","volume":"53","author":"Vos","year":"2011","journal-title":"Tijdschrift voor Psychiatrie"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0089|cit89","doi-asserted-by":"crossref","unstructured":"Vos S Van Rossum I Verhey F Soininen H Wahlund L-O Hampel H Cerebrospinal fluid markers for predicting Alzheimer's-type dementia in subjects with amnestic versus nonamnestic mild cognitive impairment Alzheimer's and Dementia 2012","DOI":"10.1016\/j.jalz.2012.05.698"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0090|cit90","doi-asserted-by":"crossref","unstructured":"Vos S van Rossum I Burns L Knol D Scheltens P Soininen H Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI Neurobiology of Aging 2012 2272 81","DOI":"10.1016\/j.neurobiolaging.2011.12.017"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0091|cit91","doi-asserted-by":"crossref","unstructured":"Wahlund LO Blennow K Cerebrospinal fluid biomarkers for disease stage and intensity in cognitively impaired patients Neuroscience Letters 2003 99 102","DOI":"10.1016\/S0304-3940(02)01483-0"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0092|cit92","doi-asserted-by":"crossref","unstructured":"Zetterberg H Pedersen M Lind K Svensson M Rolstad S Eckerstrom C Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years Journal of Alzheimer's Disease 2007 255 60","DOI":"10.3233\/JAD-2007-12307"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0093|cit93","article-title":"Predicitve value of CSF biomarkers for Alzheimer's disease in a cohort of patients with mild cognitive impairment","volume":"VII Congresso S","author":"Rainero","year":"2012","journal-title":"Conference abstracts. Proceedings"},{"issue":"11","key":"10.1002\/14651858.CD008782.pub4-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","article-title":"Frequent amyloid deposition without significant cognitive Impairment among the elderly","volume":"65","author":"Aizenstein","year":"2008","journal-title":"Archives of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD008782.pub4-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"270-9. [10.1016","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"12","key":"10.1002\/14651858.CD008782.pub4-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1001\/archneur.1994.00540240042014","article-title":"Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. The National Institute of Mental Health Genetics Initiative","volume":"51","author":"Blacker","year":"1994","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0097|cit97","article-title":"Improving services and support for people with dementia","author":"Bourne","year":"2007","journal-title":"National Audit Office"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1017\/S1041610204000092","article-title":"Is MCI really just early dementia? A systematic review of conversion studies","volume":"16","author":"Bruscoli","year":"2004","journal-title":"International Psychogeriatrics"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.arr.2004.01.002","article-title":"Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease","volume":"3","author":"Castellani","year":"2004","journal-title":"Ageing Research Reviews"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0100|cit100","first-page":"Art. No.: CD010","article-title":"Neuropsychological tests for the diagnosis of Alzheimer\u2019s disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studies","author":"Davis","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0101|cit101","author":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd revised edition. Washington","year":"1987","journal-title":"DC: American Psychiatric Association"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0102|cit102","author":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington","year":"1994","journal-title":"DC: American Psychiatric Association"},{"issue":"11","key":"10.1002\/14651858.CD008782.pub4-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1474-4422(10)70223-4","article-title":"Revising the definition of Alzheimer's disease: a new lexicon","volume":"9","author":"Dubois","year":"2010","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","article-title":"Global prevalence of dementia: a Delphi consensus study","volume":"366","author":"Ferri","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD008782.pub4-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/WNN.0b013e318145a8c8","article-title":"The genetics of very early onset Alzheimer disease","volume":"20","author":"Filley","year":"2007","journal-title":"Cognitive and Behavioural Neurology"},{"issue":"5-6","key":"10.1002\/14651858.CD008782.pub4-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1159\/000084709","article-title":"Mild cognitive impairment: an operational definition and its conversion rate to Alzheimer's disease","volume":"19","author":"Geslani","year":"2005","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"5054","key":"10.1002\/14651858.CD008782.pub4-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","article-title":"Long-term effects of A\u00df42 immunisation in Alzheimer\u2019s disease: follow-up of a randomised, placebo-controlled phase I trial","volume":"372","author":"Holmes","year":"2008","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0109|cit109","first-page":"CD010945","article-title":"Plasma and Cerebrospinal fluid (CSF) Abeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care setting","volume":"1","author":"Kokkinou","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD008782.pub4-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/jnnp.57.4.416","article-title":"Clinical and neuropathological criteria for frontotemporal dementia [Consensus statement]","volume":"57","author":"The Lund and Manchester Groups","year":"1994","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD008782.pub4-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1532-5415.2008.01820.x","article-title":"Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree?","volume":"56","author":"Matthews","year":"2008","journal-title":"Journal of the American Geriatrics Society"},{"issue":"4","key":"10.1002\/14651858.CD008782.pub4-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2009.1064","article-title":"CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment","volume":"302","author":"Mattsson","year":"2009","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD008782.pub4-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop","volume":"47","author":"McKeith","year":"1996","journal-title":"Neurology"},{"issue":"7","key":"10.1002\/14651858.CD008782.pub4-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0304-3940(01)01754-2","article-title":"Amyloid b protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease","volume":"304","author":"Mehta","year":"2001","journal-title":"Neuroscience Letters"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1600-0447.2008.01326.x","article-title":"Rate of progression of mild cognitive impairment to dementia - meta-analysis of 41 robust inception cohort studies","volume":"119","author":"Mitchell","year":"2009","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"4","key":"10.1002\/14651858.CD008782.pub4-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000017050","article-title":"Accuracy of clinical operational diagnostic criteria for Alzheimer's disease in relation to different pathological diagnostic protocols","volume":"9","author":"Nagy","year":"1998","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"3","key":"10.1002\/14651858.CD008782.pub4-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1016\/j.jalz.2012.01.014","article-title":"Systematic review of the body of evidence for use of biomarkers in the diagnosis of dementia","volume":"9","author":"Noel-Storr","year":"2013","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0120|cit120","first-page":"183","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"Journal of Internal Medicine 2004"},{"issue":"5","key":"10.1002\/14651858.CD008782.pub4-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/archneur.63.5.665","article-title":"Neuropathologic features of amnestic mild cognitive impairment","volume":"63","author":"Petersen","year":"2006","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0122|cit122","article-title":"IQCODE for the diagnosis of Alzheimer's disease dementia and other dementias within a community setting","author":"Quinn","year":"2012","journal-title":"Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD010079 DOI: 10.1002\/14651858.CD010079"},{"issue":"2","key":"10.1002\/14651858.CD008782.pub4-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop","volume":"43","author":"Roman","year":"1993","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/nm1782","article-title":"Amyloid-b protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nature Medicine"},{"issue":"7","key":"10.1002\/14651858.CD008782.pub4-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1212\/01.wnl.0000238517.59286.c5","article-title":"Ten-year risk of dementia in subjects with mild cognitive impairment","volume":"67","author":"Visser","year":"2006","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD008782.pub4-BIB0127|cit127","article-title":"International Statistical Classification of Diseases and Related Health Problems (ICD-10 Version: 2010)","author":"World Health Organization","journal-title":"http:\/\/apps.who.int\/classifications\/icd10\/browse\/2010\/en (accessed 9 January 2013)"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD008782.pub4\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T08:33:10Z","timestamp":1715070790000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008782.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Dementia and Cognitive Improvement Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,6,10]]},"references-count":127,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008782.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,10]]}}}